Rosuvastatin and other drugs from the statin class of medications are considered as a first-line options for the treatment of dyslipidemia. This is largely due to the fact that cardiovascular disease (CVD), which includes heart attack, atherosclerosis, angina, peripheral artery disease, and stroke, has become a leading cause of death in high-income countries and a major cause of morbidity around the world. Elevated cholesterol levels, and in particular, elevated low-density lipoprotein (LDL) levels, are an important risk factor for the development of CVD. Statins are considered a cost-effective treatment option for CVD due to their evidence of reducing all-cause mortality including fatal and non-fatal CVD as well as the need for surgical revascularization or angioplasty following a heart attack.
Fenofibrate is a peroxisome proliferator receptor alpha activator used to lower LDL-C, total-C, triglycerides, and Apo B, while increasing HDL-C in hypercholesterolemia, dyslipidemia, and hypertriglyceridemia.
Rosuvastatin 5/10/20mg Tablets & Rosuvastatin 10mg + Fenofibrate 160mg Tablets
MODE OF ACTION:
Rosuvastatin is a lipid-lowering medication (statin). It works by blocking an enzyme (HMG-CoA-reductase) that is required by the body to make cholesterol, thereby lowering “bad” cholesterol (LDL) and triglycerides and raising “good” cholesterol (HDL). Fenofibrate is a lipid lowering medication. It works by lowering the levels of triglycerides and “bad” cholesterol (LDL), while raising the levels of “good” cholesterol (HDL).
- Primary prevention of ASCVD
- Treatment of high cholesterol
As per doctor’s direction
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.